Twelve Infants Die During Clinical Trials for FDA-Endorsed RSV Drug
On June 8, 2023, the U.S. Food and Drug Administration’s (FDA) Antimicrobial Drugs Advisory Committee (AMDAC) voted unanimously (21-0) in favor of AstraZeneca and Sanofi’s new nirsevimab (Beyfortus) monoclonal antibody drug believed to provide protection for infants from respiratory syncytial virus (RSV) disease and other lower respiratory tract infections during their first year of life.1 […]
More U.S. Parents Reject HPV Vaccine Over Safety Concerns
A growing number of parents in the U.S. are choosing not to vaccinate their adolescent children for human papillomavirus (HPV), according to a new study published in the June 2023 edition of the journal Pediatrics.1 The study identified HPV vaccine uptake trends in an effort to develop strategies to combat increasing vaccine hesitancy. The researchers […]
RSV Vaccine Approved by FDA for Adults 60 and Older
The U.S. Food and Drug Administration (FDA) has approved a license for the world’s first respiratory syncytial virus (RSV) vaccine to be given to people 60 years of age and older. Pharmaceutical and biotechnology company GSK (formerly GlaxoSmithKline) has already begun manufacturing doses of the vaccine, which will be sold as early as this fall […]
Homebirthed Newborn in Texas Forcibly Taken Away from Parents
In a case that highlights the growing power struggle between doctors, government officials and parents over medical treatment of children, a Black couple was finally reunited with their newborn daughter more than three weeks after the Texas Department of Family and Protective Services placed her in foster care over a disagreement about how the infant […]
U.S. to Spend Billions on New COVID Vaccines Despite Failure to Prevent Infection
The Biden administration announced earlier this month that the U.S. government will spend at least $5 billion on Project NextGen to rapidly develop “next-generation” SARS-CoV-2 vaccines and treatments despite evidence that current COVID vaccines do not prevent infection and transmission of the new coronavirus.1 Following a similar approach to “Operation Warp Speed” initiated by the […]
Women 3.5 Times More Likely to Develop Heart Disease or Die Suddenly After AstraZeneca COVID Vaccine
A new report shows that women aged 12-29 who received AstraZeneca/Oxford University’s Vaxzevria adenovirus vectored COVID-19 vaccine are three and a half times more likely to develop heart disease, suffer sudden death, or both, in the 12 days post vaccination.1 The statistical model linked 11 out of 15 cardiac deaths directly to Vaxzevria, also citing […]
